Literature DB >> 15072497

Development of Peyronie's disease during long-term colchicine treatment.

Tibet Erdogru1, Mustafa F Usta, Mutlu Ates, Sahin Yigit.   

Abstract

Colchicine has been reported to be a safe and effective medication in the treatment of early phase of Peyronie's disease (PD). However here we reported two patients, presenting with PD during high dose colchicine treatment for familiar mediterranean fever (FMF).

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 15072497     DOI： 10.1023/b:urol.0000020297.67752.b3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


  5 in total

1.  Treatment of Peyronie's disease with oral colchicine: long-term results and predictive parameters of successful outcome.

Authors:  A Kadioglu; A Tefekli; T Köksal; M Usta; H Erol
Journal:  Int J Impot Res       Date:  2000-06       Impact factor: 2.896

2.  Colchicine plasma levels. Implications as to pharmacology and mechanism of action.

Authors:  S L Wallace; B Omokoku; N H Ertel
Journal:  Am J Med       Date:  1970-04       Impact factor: 4.965

3.  The effects of colchicine on a Peyronie's-like condition in an animal model.

Authors:  A I El-Sakka; M E Bakircioglu; R S Bhatnagar; T S Yen; R Dahiya; T F Lue
Journal:  J Urol       Date:  1999-06       Impact factor: 7.450

4.  Clinical and cellular effects of colchicine in fibromatosis.

Authors:  H R Dominguez-Malagon; A Alfeiran-Ruiz; P Chavarria-Xicotencatl; M S Duran-Hernandez
Journal:  Cancer       Date:  1992-05-15       Impact factor: 6.860

5.  Is colchicine effective in Peyronie's disease? A pilot study.

Authors:  E Akkus; S Carrier; J Rehman; J Breza; A Kadioglu; T F Lue
Journal:  Urology       Date:  1994-08       Impact factor: 2.649
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.